Actively Recruiting

All Genders
Healthy Volunteers
NCT06972784

Xiangya Cardiopulmonary Health and Disease Cohort

Led by Xiangya Hospital of Central South University · Updated on 2025-07-02

30000

Participants Needed

1

Research Sites

547 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Xiangya Cardiopulmonary Health and Disease Cohort (XY-CPHDC) is a non-intervention study grounded in real-world data. It is designed as a bidrectional clinical cohort combined retrospective and prospective design, in order to evaluate cardiopulmonary function systematically and holistically, integrate physiology and medical theory, and explore the changing pattern of the cardiopulmonary under different health states. Cardiovascular System and Respiratory System are closely linked and interdependent physiological systems, and they play a vital role in maintaining normal life activities in the human body. Patients with cardiopulmonary disease often have conspicuous comorbidity characteristics, however, current measurements of cardiopulmonary function indicators are mostly limited to the assessments of single organ. This pattern of subspecialty care leads to deficiencies in the recognition of cardiopulmonary synergy dysfunction, and there is an urgent need for a more comprehensive and systematic approach to assessment. This study plans to construct a cardiopulmonary holistic assessment cohort, aiming at comprehensively and systematically reveal the intrinsic connection between the cardiopulmonary function in different scenarios, such as resting, exercise, and sleep, to deeply explore the core indicators of cardiopulmonary holistic function, to construct a joint stratification system of cardiopulmonary function, and to map cardiopulmonary comorbidity spectrum, so that they can accurately guide the diagnosis of the disease, the prognostic prediction and the intervention strategies.

CONDITIONS

Official Title

Xiangya Cardiopulmonary Health and Disease Cohort

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients treated or hospitalized at Xiangya Hospital between January 2010 and April 2025
  • Completion of cardiac and pulmonary function assessments within one year
  • Complete clinical diagnostic and treatment information available
  • For prospective cohort: previously included in retrospective cohort
  • Signed informed consent for at least 3 years of follow-up
  • Able to complete baseline assessment and stable for follow-up
Not Eligible

You will not qualify if you...

  • Missing cardiopulmonary function test reports or key data
  • Missing important clinical diagnostic or treatment data
  • Severe cognitive impairment, psychiatric disease, or communication disorder
  • Expected survival time less than 3 years
  • Incomplete cardiopulmonary or clinical data at baseline
  • Participation in other interventional clinical trials affecting cardiopulmonary assessment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xiangya Hospital, Central South University Affiliated

Changsha, Hunan, China, 457500

Actively Recruiting

Loading map...

Research Team

Y

yuan zhang, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here